Semaglutide injection (Jiangsu Chia Tai-Tianqing)

索马鲁肽注射液 (正大天晴)

Report date: 2025/03/07 16:55:44

Base Information

Drug NameSemaglutide injection (Jiangsu Chia Tai-Tianqing)
Drug Alias Name司美格鲁肽注射液TQF-3510
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightBody WeightObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A